Predicting response to multidrug regimens in cancer patients using cell line experiments and regularised regression models-Reference-Cited by-同舟云学术

Predicting response to multidrug regimens in cancer patients using cell line experiments and regularised regression models

Published:2015-04-08 Issue:1 Volume:15 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Falgreen Steffen,Dybkær Karen,Young Ken H,Xu-Monette Zijun Y,El-Galaly Tarec C,Laursen Maria Bach,Bødker Julie S,Kjeldsen Malene K,Schmitz Alexander,Nyegaard Mette,Johnsen Hans Erik,Bøgsted Martin

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/article/10.1186/s12885-015-1237-6/fulltext.html

Reference61 articles.

1. Friedberg JW. New strategies in diffuse large B-cell lymphoma: translating findings from gene expression analyses into clinical practice. Clin Cancer Res. 2011;17:6112–7.

2. Lee JK, Havaleshko DM, Cho H, Weinstein JN, Kaldjian EP, Karpovich J, et al. A strategy for predicting the chemosensitivity of human cancers and its application to drug discovery. Proc Natl Acad Sci U S A. 2007;104:13086–91.

3. Lee JK, Coutant C, Kim Y-C, Qi Y, Theodorescu D, Symmans WF, et al. Prospective comparison of clinical and genomic multivariate predictors of response to neoadjuvant chemotherapy in breast cancer. Clin Cancer Res. 2010;16:711–8.

4. Boegsted M, Holst JM, Fogd K, Falgreen S, Sørensen S, Schmitz A, et al. Generation of a predictive melphalan resistance index by drug screen of B-cell cancer cell lines. PLoS One. 2011;6:e19322.

5. Chen J-J, Knudsen S, Mazin W, Dahlgaard J, Zhang B. A 71-gene signature of TRAIL sensitivity in cancer cells. Mol Cancer Ther. 2012;11:34–44.

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pan-Cancer Drug Response Prediction Using Integrative Principal Component Regression;Statistics in Biosciences;2024-08-18

2. CRISPR-Cas9 Knockout Screens Identify DNA Damage Response Pathways and BTK as Essential for Cisplatin Response in Diffuse Large B-Cell Lymphoma;Cancers;2024-07-02

3. Computational precision therapeutics and drug repositioning;Comprehensive Precision Medicine;2024

4. Pan-Cancer Drug Response Prediction Using Integrative Principal Component Regression;2023-10-05

5. Machine learning-driven exploration of drug therapies for triple-negative breast cancer treatment;Frontiers in Molecular Biosciences;2023-08-04